ClinicalTrials.Veeva

Menu

The Relationship Between HLA Tissue Compatibility and Biliary Complications in Patients With Liver Transplantation

I

Inonu University

Status

Completed

Conditions

Liver Transplant; Complications
HLA Antigens

Treatments

Other: HLA antigen results

Study type

Observational

Funder types

Other

Identifiers

NCT04885582
2017/133

Details and patient eligibility

About

Liver transplantation has become the accepted treatment option for advanced liver failure in recent years. In addition to the increase in the number of centers performing transplant and the decrease in complication rates depending on the experience gained, the most common biliary complications did not improve at the desired level. For this reason, studies in this field are frequent today.

The structural complexities of HLA antigens have been the subject of investigation in recent years. With the development of DNA and RNA amplification methods; It is increasingly difficult for physicians to keep up with the increasing burden of knowledge regarding the genetic aspects of these antigens. Concrete benefits of this gene complex, which has been investigated in various fields and preserves its mystery, have not been determined in liver transplant patients. However, there are publications showing its connection with the bile epithelium in liver transplantation and its relationship with the disappearing bile duct syndrome. In this study, our aim is to explain whether the bile duct complications, which appear like a continuous wall and can lead to frightening pictures, are related to HLA tissue compatibility.

Enrollment

80 patients

Sex

All

Ages

1 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients with liver transplantation and tested for HLA antigen (recipient - donor)

Exclusion criteria

  • patients who died early Patients whose HLA antigen is not checked

Trial design

80 participants in 2 patient groups

Patients with biliary complications
Description:
patients with postoperative biliary fistula, biliary stenosis
Treatment:
Other: HLA antigen results
Patients without biliary complications
Description:
patients without postoperative biliary fistula and biliary stenosis
Treatment:
Other: HLA antigen results

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems